References
- Cannon CP, Braunwald E. Unstable angina and non-ST elevation myocardial infarction. In: Zipes DP, Libby P, Bonow RO, editors. Heart disease. 7th ed. Philadelphia (PA): Elsevier Saunders; 2005. p. 1243–1279.
- Sianos G, Papafaklis MI, Daemen J, et al. Angiographic stent thrombosis after routine use of drug-eluting stents in ST segment elevation myocardial infarction: the importance of thrombus burden. J Am Coll Cardiol. 2007;50(7):573–583.
- Goto K, Lansky AJ, Nikolsky E, et al. Prognostic significance of coronary thrombus in patients undergoing percutaneous coronary intervention for acute coronary syndromes: a subanalysis of the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial. JACC Cardiovasc Interv. 2011;4(7):769–777.
- January CT, Wann LS, Alpert JS, et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014;64(21):e1–e76.
- Seyis S, Kurmuş Ö, Kiliç S, et al. CHA2DS2-VASc score predicts intracoronary thrombus burden in patients with ST-elevation myocardial infarction. Biomed Res. 2017;28(18):8050–8054.
- Ipek G, Onuk T, Karatas MB, et al. CHA2DS2-VASc score is a predictor of no-reflow in patients with ST-segment elevation myocardial infarction who underwent primary percutaneous intervention. Angiology. 2016;67(9):840–845.
- Keskin K, Sezai Yıldız S, Çetinkal G, et al. The value of CHA2DS2-VASc score in predicting all-cause mortality in patients with ST-segment elevation myocardial infarction who have undergone primary percutaneous coronary intervention. Acta Cardiol Sin. 2017;33(6):598–604.
- Onuk T, Karataş MB, İpek G, et al. Higher CHA2DS2VASc score is associated with increased mortality in acute pulmonary embolism. Clin Appl Thromb Hemost. 2017;23(6):631–637.
- Roffi M, Patrono C, Collet JP, et al. 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Rev Esp Cardiol. 2015;68(12):1125.
- Camm AJ, Kirchhof P, Lip GYH, et al. Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC). European Heart Rhythm Association, European Association for Cardio-Thoracic Surgery. Eur Heart J. 2010;31(19):2369–2429.
- Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612.
- Cheitlin MD, Armstrong WF, Aurigemma GP, et al. ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography-summary article: a report of the American college of cardiology/American heart association task force on practice guidelines (ACC/AHA/ASE committee to update the 1997 guidelines for the clinical application of echocardiography). J Am Coll Cardiol. 2003;42(5):954–970.
- Tanboga IH, Topcu S, Aksakal E, et al. Determinants of angiographic thrombus burden in patients with ST-segment elevation myocardial infarction. Clin Appl Thromb Hemost. 2014;20(7):716–722.
- Duman H, Çinier G, Bakırcı EM, et al. Relationship between C-reactive protein to albumin ratio and thrombus burden in patients with acute coronary syndrome. Clin Appl Thromb Hemost. 2019;25.
- Bakirci EM, Degirmenci H, Duman H, et al. Increased epicardial adipose tissue thickness is associated with angiographic thrombus burden in the patients with non-ST-segment elevation myocardial infarction. Clin Appl Thromb Hemost. 2015;21(7):612–618.
- Cetin M, Cakici M, Zencir C, et al. Prediction of coronary artery disease severity using CHADS2 and CHA2DS2-VASc scores and a newly defined CHA2DS2-VASc-HS score. Am J Cardiol. 2014;113(6):950–956.
- Rozenbaum Z, Elis A, Shuvy M, et al. CHA2DS2VASc score and clinical outcomes of patients with acute coronary syndrome. Eur J Intern Med. 2016;36:57–61.
- Milasinovic D, Milosevic A, Marinkovic J, et al. Timing of invasive strategy in NSTEACS patients and effect on clinical outcomes: a systematic review and metaanalysis of randomized controlled trials. Atherosclerosis. 2015;241(1):48–54.